Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | +8.39% | +2.31% | -5.68% |
Jun. 07 | Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing | MT |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.68% | 2.04B | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- JPMorgan Trims Price Target on Recursion Pharmaceuticals to $10 From $11, Maintains Neutral Rating